(856) 673-3000

The New Year brings with it new US federal serialization mandates (FDA: DQSA/DSCSA) which in turn starts the journey of implementing a more robust track and trace solution for the players in the life sciences industry. Even though the current regulations require tracking at the batch level, the need for end-to-end serialization is not far behind.

Meeting this new regulation can be looked at in two ways: 1) Only implementing a solution to meet compliance or 2) Implementing a solution that allows your company to extract valuable information from all of this new serialization data. The second option truly leverages the investment to one’s advantage. John DiPalo, CSO of ACSIS Inc., notes “Government mandates calling for unit-level serialization are not optional. A byproduct of these mandates is the ability to better protect your brands as well as improve operational efficiencies by using this data at the operational level.”

Below is John’s list of seven benefits that serialization can afford your organization:

  1. Track data on every single unit, resulting in visibility to the most granular level.
  2. Leverage the serialization data in order to boost order accuracy.
  3. Analyze every facet of order fulfillment to speed processing and improve customer service.
  4. Spotlight and streamline inefficient processes and redundant effort to spot the micro inefficiencies in your supply network.
  5. Integrate automated material handling equipment.
  6. Facilitate efficient receiving and disposition of returns.
  7. Improved order fulfillment, productivity, and data accuracy in the warehouse.

If any of the aforementioned benefits seem valuable to you, consider adding serialization to your ‘To Do’ list for 2015.

For more information on the ACSIS Serialization Management solution, click here.
And to view our infographic that provides insight into all future serialization mandates, click here.